Phase
Condition
Toenail Fungus (Onychomycosis)
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Ages 18 years old and above
Established and active diagnosis of distal subungual onychomycosis of at least onehallux nail affecting 20-75% of the hallux nail
Positive culture for dermatophytes and positive potassium hydroxide examination
Provide signed and dated informed consent
Willing to comply with all study procedures and available for the duration of thestudy
Exclusion
Exclusion Criteria:
Known allergic reaction to the study products
Unable to provide signed and dated informed consent form
Unable or unwilling to comply with all study procedures and/or unavailable forduration of the study
Thickness of mycotic nail is greater than 3mm
Less than 2mm of clear nail at the proximal aspect
History of rheumatoid arthritis
Subject with any other disease or condition other than DSO that would affect nailappearance or interfere with image analysis
Unwilling or unable to limit use of nail polish for duration of study
Known history of PVD, immune system concerns, or ongoing chemotherapy
Severe moccasin tinea pedis
Prior systemic antifungal drugs 6 months before study start date
Prior topical therapy for toenail fungus 2 months before study start date
Any diseases or circumstances in which the patient should not participate in the studyin the opinion of the investigator
Study Design
Study Description
Connect with a study center
Doctors Research Network
South Miami, Florida 33143
United StatesActive - Recruiting


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.